Therefore, understanding the mechanisms and consequences of NLRP3 inflammasome activation in cancer is critical for developing novel therapeutic strategies (Hamarsheh and Zeiser, 2020) (Figure 2). This evidence concerns the gene NLRP3 and cancer.